Cardiolipin Antibody (IgG) - Serum
This test measures the presence of antibodies against cardiolipin, a component found in cell membranes, often linked to autoimmune conditions.
["Helps evaluate potential autoimmune or inflammatory responses in your blood."]
Key facts at a glance
- LOINC
- 45057-7
- Short code
- ACAPNL
- Synonyms
- Cardiolipin IgA+IgG+IgM Pnl Ser
- Category
- chemistry
- Sample
- serum
- Container
- Serum separator tube (SST) or red-top tube without anticoagulant
- Units
- N/A
- Ref low
- 0
- Ref high
- 10
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Enzyme-Linked Immunosorbent Assay (ELISA)
- CPT
- 86147x3
- SNOMED
- 395111002
- Specimen volume
- 1-2 mL of serum (minimum 0.5 mL)
- Stability
- Serum stable for 8 hours at room temperature, 7 days at 2-8°C, or 3 months at -20°C. Avoid repeated freeze-thaw cycles.
- Hemolysis max
- 100
- Lipemia max
- 100
- Icterus max
- 50
- TAT
- 24–72 hours
- Order
- routine
What Is Cardiolipin Antibody Testing Used For?
Cardiolipin antibodies are sometimes checked when doctors suspect autoimmune disorders, such as lupus or other connective tissue diseases. They may also be considered in patients with unexplained blood clots or heart-related symptoms, though they are not the primary test for these conditions alone.
How Is This Test Performed?
A blood sample is drawn from a vein in your arm. The sample is sent to a lab where it is tested using an immunoassay method to detect cardiolipin-specific IgG antibodies. Results are reported as either positive or negative, without a standard numeric range.
What Might High or Low Results Indicate?
Positive results suggest an immune response against cardiolipin, which can be associated with autoimmune conditions like antiphospholipid syndrome (APS) or lupus. However, false positives can occur, so further evaluation by your healthcare provider is needed.
When Might You Need This Test?
Your doctor may order this test if you have symptoms like unexplained blood clots, recurrent miscarriages, heart valve issues, or other signs of autoimmune activity. It is sometimes included in broader screening for conditions like lupus or other connective tissue diseases.
Reference range
Negative: <10 GPL U/mL (IgG), <10 MPL U/mL (IgM), <10 APL U/mL (IgA); Positive: ≥10 GPL/MPL/APL U/mL. Results reported separately for IgA, IgG, and IgM isotypes.N/A
No fasting required. Patient should be well-hydrated. Avoid sample collection during active infection or inflammation if possible, as this may elevate anticardiolipin antibody titers.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Cardiolipin antibodies are part of a group of antiphospholipid antibodies that may contribute to autoimmune disorders. While they can be detected in people with conditions like lupus or antiphospholipid syndrome, they are not definitive on their own. Doctors use them as part of a broader evaluation to assess risk for complications like blood clots or pregnancy complications.
Short name
IgG Cardiolipin Antibody
Frequently asked questions
Why might my doctor recommend this test?
What does a positive result mean for my health?
Do I need to prepare for this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 15, 2026. · Read our editorial policy